Oncolytic H-1 parvovirus shows safety and signs of immunogenic activity in a first phase I/IIa glioblastoma trial - Geletneky, Karsten; Hajda, Jacek; Beelte, Birgit; Capper, David; Bartsch, Andreas J.; Neumann, Jan-Oliver; Schöning, Tilman; Hüsing, Johannes; Deimling, Andreas von; Daniel, Volker; Unterberg, Andreas (Molecular therapy, 2017)
Gesehen am 02.05.2018